| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A Jon Stoess. Functional imaging studies of non-motoric manifestations of Parkinson's Disease. Parkinsonism & related disorders. vol 15 Suppl 3. 2010-03-31. PMID:20082973. |
this will depend upon the ability to investigate non dopaminergic mechanisms as well as extra-striatal release of dopamine and the capacity to assess the impact of behaviourally relevant stimuli on neurotransmitter release and on networks of brain activation. |
2010-03-31 |
2023-08-12 |
Not clear |
| P R Hollan. Modulation of trigeminovascular processing: novel insights into primary headache disorders. Cephalalgia : an international journal of headache. vol 29 Suppl 3. 2010-03-23. PMID:20017748. |
the identification of novel neurotransmitter systems (orexinergic, cannabinoid and dopaminergic) within this descending pathway and their interaction with 5-ht(1b/1d) (triptan) receptors provides important clues about several of the risk factors and comorbidities associated with primary headache disorders and indicates that triptans exert central as well as peripheral activity. |
2010-03-23 |
2023-08-12 |
Not clear |
| S V Lelevich, V V Lelevich, A A Novokshono. Neurotransmitter mechanisms of morphine withdrawal syndrome. Bulletin of experimental biology and medicine. vol 148. issue 2. 2010-03-15. PMID:20027323. |
dysfunction was revealed in the dopaminergic, noradrenergic, and serotoninergic neurotransmitter systems. |
2010-03-15 |
2023-08-12 |
rat |
| Hana Kovaru, Marek Pav, Frantisek Kovaru, Jiri Raboch, Anna Fiserov. Cell signalling in CNS and immune system in depression and during antidepressant treatment: focus on glial and natural killer cells. Neuro endocrinology letters. vol 30. issue 4. 2010-03-08. PMID:20010506. |
depression is associated with abnormalities in the noradrenergic, serotonergic and dopaminergic neurotransmitter systems and reductions in the level of their precursors and metabolic turnover. |
2010-03-08 |
2023-08-12 |
human |
| Kaisa Riala, Helinä Hakko, Anja Taanila, Pirkko Räsäne. Season of birth and smoking: findings from the Northern Finland 1966 Birth Cohort. Chronobiology international. vol 26. issue 8. 2010-03-02. PMID:20030548. |
season of birth may modify the development of dopaminergic or other neurotransmitter systems divergently among males and females. |
2010-03-02 |
2023-08-12 |
Not clear |
| Rodney C Samaco, Caleigh Mandel-Brehm, Hsiao-Tuan Chao, Christopher S Ward, Sharyl L Fyffe-Maricich, Jun Ren, Keith Hyland, Christina Thaller, Stephen M Maricich, Peter Humphreys, John J Greer, Alan Percy, Daniel G Glaze, Huda Y Zoghbi, Jeffrey L Neu. Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities. Proceedings of the National Academy of Sciences of the United States of America. vol 106. issue 51. 2010-02-18. PMID:20007372. |
deleting mecp2 from either th-positive dopaminergic and noradrenergic neurons or pet1-positive serotonergic neurons in mice decreased corresponding neurotransmitter concentration and specific phenotypes, likely through mecp2 regulation of rate-limiting enzymes involved in aminergic neurotransmitter production. |
2010-02-18 |
2023-08-12 |
mouse |
| Chee Yeun Chung, James B Koprich, Penelope J Hallett, Ole Isacso. Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression. Proceedings of the National Academy of Sciences of the United States of America. vol 106. issue 52. 2010-02-17. PMID:20007772. |
rab3b overexpression in human dopaminergic be (2)-m17 cells increased neurotransmitter content, [(3)h] dopamine uptake, and levels of presynaptic proteins. |
2010-02-17 |
2023-08-12 |
human |
| Mei-Fang Xiao, Jin-Chong Xu, Yuliya Tereshchenko, Daniel Novak, Melitta Schachner, Ralf Kleen. Neural cell adhesion molecule modulates dopaminergic signaling and behavior by regulating dopamine D2 receptor internalization. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 29. issue 47. 2010-01-12. PMID:19940170. |
these results demonstrate that, in addition to its classical function in cell adhesion, ncam is involved in regulating the trafficking of the neurotransmitter receptor d(2)r as well as receptor-mediated signaling and behavior, thus implicating ncam as modulator of the dopaminergic system and a potential pharmacological target for dopamine-related neurological and psychiatric disorders. |
2010-01-12 |
2023-08-12 |
mouse |
| D Armbruster, A Mueller, D A Moser, K P Lesch, B Brocke, C Kirschbau. Interaction effect of D4 dopamine receptor gene and serotonin transporter promoter polymorphism on the cortisol stress response. Behavioral neuroscience. vol 123. issue 6. 2010-01-05. PMID:20001112. |
the dopaminergic and the serotonergic neurotransmitter system have been found to modulate the amygdala-connected circuitries that are crucial in emotional modulation and response to fearful stimuli. |
2010-01-05 |
2023-08-12 |
Not clear |
| Courtney A Ficks, Irwin D Waldma. Gene-environment interactions in attention-deficit/hyperactivity disorder. Current psychiatry reports. vol 11. issue 5. 2010-01-04. PMID:19785980. |
genetic associations with adhd have been found in the dopaminergic, serotonergic, and noradrenergic neurotransmitter systems, but findings are inconsistent across studies. |
2010-01-04 |
2023-08-12 |
Not clear |
| Steven L Small, Daniel A Llan. Biological approaches to aphasia treatment. Current neurology and neuroscience reports. vol 9. issue 6. 2009-12-15. PMID:19818231. |
several randomized controlled clinical trials involving manipulation of different neurotransmitter systems, including noradrenergic, dopaminergic, cholinergic, and glutamatergic systems, have shown signals of efficacy. |
2009-12-15 |
2023-08-12 |
Not clear |
| G A Oganesyan, I V Romanova, E A Aristakesyan, V V Kuzik, D M Makina, I Yu Morina, A E Khramenkova, I V Artamokhina, V A Belov. The dopaminergic system of the telencephalo-diencephalic areas of the vertebrate brain in the organization of the sleep-waking cycle. Neuroscience and behavioral physiology. vol 39. issue 8. 2009-10-05. PMID:19779833. |
these data are discussed in the light of the phylo- and ontogenetic development of the neurosecretory and neurotransmitter functions of the dopaminergic system in the evolutionarily ancient diencephalic and evolutionarily young telencephalic areas of the vertebrate brain as major systems triggering and maintaining the functional states of the body during the sleep-waking cycle. |
2009-10-05 |
2023-08-12 |
rat |
| Anne-Sophie Rolland, Dominique Tandé, Maria-Trinidad Herrero, Maria-Rosario Luquin, Marianne Vazquez-Claverie, Carine Karachi, Etienne C Hirsch, Chantal Françoi. Evidence for a dopaminergic innervation of the pedunculopontine nucleus in monkeys, and its drastic reduction after MPTP intoxication. Journal of neurochemistry. vol 110. issue 4. 2009-09-21. PMID:19527435. |
taking into account the role of dopamine (da) in motor control and its degeneration in parkinson's disease, this neurotransmitter could induce dysfunction in the ppn and cun through a direct dopaminergic innervation of these brainstem structures. |
2009-09-21 |
2023-08-12 |
monkey |
| Hajime Hirasawa, Michelino Puopolo, Elio Raviol. Extrasynaptic release of GABA by retinal dopaminergic neurons. Journal of neurophysiology. vol 102. issue 1. 2009-09-10. PMID:19403749. |
gaba release by dopaminergic amacrine (da) cells of the mouse retina was detected by measuring cl- currents generated by isolated perikarya in response to their own neurotransmitter. |
2009-09-10 |
2023-08-12 |
mouse |
| Y M Choi, J Y Jang, M Jang, S H Kim, Y K Kang, H Cho, S Chung, M K Par. Modulation of firing activity by ATP in dopamine neurons of the rat substantia nigra pars compacta. Neuroscience. vol 160. issue 3. 2009-08-19. PMID:19272429. |
atp acts as a neurotransmitter or co-neurotransmitter in many areas of the cns and peripheral nervous systems; however, little is known about the expression and functional role of purinoceptors (p2) in midbrain dopaminergic neurons. |
2009-08-19 |
2023-08-12 |
rat |
| Fernando Veiga Fernández, Alfonso J Cruz Jentof. [Delirium: etiology and pathophysiology]. Revista espanola de geriatria y gerontologia. vol 43 Suppl 3. 2009-08-17. PMID:19422109. |
functional changes occur in a large number of neurotransmitters: the most frequent and best characterized are a reduction of cholinergic function and an increase in dopaminergic and gabaergic function, although alterations in almost all neurotransmitter systems (serotoninergic, noradrenergic, glutaminergic, histaminergic) have been found. |
2009-08-17 |
2023-08-12 |
Not clear |
| Xenia Borue, Stephanie Cooper, Jay Hirsh, Barry Condron, B Jill Vento. Quantitative evaluation of serotonin release and clearance in Drosophila. Journal of neuroscience methods. vol 179. issue 2. 2009-08-04. PMID:19428541. |
when chr2 is targeted to dopaminergic neurons, dopamine release is measured demonstrating that this method is broadly applicable to other neurotransmitter systems. |
2009-08-04 |
2023-08-12 |
drosophila_melanogaster |
| Craig Blackston. Infantile parkinsonism-dystonia: a dopamine "transportopathy". The Journal of clinical investigation. vol 119. issue 6. 2009-07-24. PMID:19504720. |
the dopamine transporter (dat) retrieves the neurotransmitter dopamine from the synaptic cleft at dopaminergic synapses. |
2009-07-24 |
2023-08-12 |
human |
| M L Persson, J Johansson, R Vumma, J Raita, L Bjerkenstedt, F-A Wiesel, N Venizelo. Aberrant amino acid transport in fibroblasts from patients with bipolar disorder. Neuroscience letters. vol 457. issue 1. 2009-07-22. PMID:19429160. |
the transport aberration could lead to disturbances in the dopaminergic and noradrenergic neurotransmitter systems. |
2009-07-22 |
2023-08-12 |
Not clear |
| M L Persson, J Johansson, R Vumma, J Raita, L Bjerkenstedt, F-A Wiesel, N Venizelo. Aberrant amino acid transport in fibroblasts from patients with bipolar disorder. Neuroscience letters. vol 457. issue 1. 2009-07-22. PMID:19429160. |
the decreased tyrosine transport (low v(max)) found in this study may indicate less access of dopamine in the brain, resulting in disturbed dopaminergic and/or noradrenergic neurotransmission, that secondarily could lead to disturbances in other central neurotransmitter systems, such as the serotoninergic system. |
2009-07-22 |
2023-08-12 |
Not clear |